期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性收缩性心力衰竭的药物治疗 被引量：1

下载PDF
导出
摘要 慢性收缩性心力衰竭患者的急性期或失代偿期需要积极改善血液动力学，缓解症状；在稳定期，从防止、延缓和逆转心肌重构的机制出发，口服神经内分泌拮抗剂是慢性收缩性心力衰竭治疗的基石。2012年欧洲急／慢性心力衰竭诊断和治疗指南纳入了一些基于循证医学的新的药物治疗观点。图1显示了慢性收缩性心力衰竭患者的治疗策略，其中盐皮质激素受体拮抗剂（MRA）在慢性收缩性心力衰竭治疗中的地位明显提高，成为关键的神经激素受体阻滞剂之一。
作者 林雪 方理刚
机构地区 中国医学科学院北京协和医学院北京协和医院心内科
出处 《临床内科杂志》 CAS 2012年第7期451-454,共4页 Journal of Clinical Internal Medicine
关键词 心力衰竭 药物治疗
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献26

  • 1Hunt SA, Abraham WT Chin MH, etal. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lunz Transtplantation. Circulation 2000 119.391-479.
  • 2McMurray JJ,Adamopoulos S,Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012:The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association ( HFA ) of the ESC. Eur Heart J,2012, Mac 19. [ Epub ahead of print].
  • 3Roosi J, Bayram M, Udelson JE, et al.Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes:insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure ( AClrIV in CHF) trial. Acute Card Care .2007.9 :82-86.
  • 4Miyazaki T, Fujiki H, Yamamum Y, et al. Tolvaptan, an orally active vasopressin V (2)-receptor antagonist-Pharmacology and clinical rims. Cardiovasc Drug Rev ,2007,25 : 1-13.
  • 5The Consensus trial study group. Effect of enalapril on mortality in se- vere congestive heart failure. Results of the Cooperative North Scandina- vian Enalapril Suvival Study ( Consensus ). N Engl J Med, 1987,316 : 1429-1435.
  • 6The SOLVD Investigators. Effect of enalapril on mortality and develop- ment of heart failure in asymptomatic patients with reduced left ventric- ular ejection fractions. N Engl J Med, 1992,327:685-691.
  • 7Loeb HS, Johnson G, Henrieh A, et al. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazonsin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation, 1993,87 : 178-187.
  • 8Rutherford JD, Pfeffer MA, Moye LA, et al. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. Circulation, 1994,90 : 1731-1738.
  • 9无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量：3696
  • 10Pitt B,Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lan- cet,2000,355 : 1582-1587.

二级参考文献42

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量：91
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3695

同被引文献12

  • 1陈艳红,单其俊.埃普利酮:一种选择性醛固酮受体拮抗剂在治疗心力衰竭中的作用[J].心血管病学进展,2004,25(5):377-380. 被引量：7
  • 2殷晓伟,杨庭树.抗神经内分泌治疗慢性心力衰竭进展[J].心血管病学进展,2007,28(5):734-738. 被引量：17
  • 3杨新春,那开宪.心力衰竭临床与实践[J].北京:人民卫生出版社,2008:42-45.
  • 4King M, Kingery JE, Casey B. Diagnosis and evaluation of heartfailure [ J]. American Family Physician, 2012, 85 C 12 ) : 1161 -1168.
  • 5Cohn JN, Bristow MR, Chien KR, et al. Report of the nationalheart,lung and blood institute special emphasis panel on heart re-search[J], Circulation, 1998,95(4) : 766 - 770.
  • 6Swedberg K, Eneroth P, Kjekshus J, et al. Hormonesregulatingcardiovascular function in patients with severecongestive heartfailure and their relation to mortality [J], Circulation, 1990, 82.5):1730 - 1736.
  • 7Palazzuoli A, Gallotta M, Quatrini I, et al. Natriuretic peptides(BNP and NT - proBNP) .. Measurement and relevance in heartfailure[J]. Vase Health Risk Manag,2010,6(3) :411 - 418.
  • 8Jorde UP, Vittorio TJ, Dimayuga CA,et al. Comparison of sup-pression of the circulating and vascular renin - angiotensin systemby enalapril versua trandolapril in chronic heart failure[J]. Am JCardiol,2004,94:1501 - 1505.
  • 9Pitt B, Zannad F.Remme WJ ,etal. The effect of spironolactoneon morbidity and mortality in patients with severe heart failure.Randomized aldactone evaluation study investigators [J]. N EnglJ Med,1999,341:709 - 717.
  • 10Siscovick DS,Raghunathan TE,Psaty BM,et aL. Diuretic therapyfor hypertension and the risk of primary cardiac arrest[J]. N EnglJ Med,1994,330:1852 - 1857.

引证文献1

临床内科杂志
2012年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部